SK bioscienceLtd Balance Sheet Health
Financial Health criteria checks 5/6
SK bioscienceLtd has a total shareholder equity of ₩1,737.8B and total debt of ₩80.0B, which brings its debt-to-equity ratio to 4.6%. Its total assets and total liabilities are ₩1,966.4B and ₩228.6B respectively. SK bioscienceLtd's EBIT is ₩4.5B making its interest coverage ratio -0.5. It has cash and short-term investments of ₩1,215.6B.
Key information
4.6%
Debt to equity ratio
₩80.00b
Debt
| Interest coverage ratio | -0.5x |
| Cash | ₩1.22t |
| Equity | ₩1.74t |
| Total liabilities | ₩228.62b |
| Total assets | ₩1.97t |
Financial Position Analysis
Short Term Liabilities: A302440's short term assets (₩1,379.2B) exceed its short term liabilities (₩136.2B).
Long Term Liabilities: A302440's short term assets (₩1,379.2B) exceed its long term liabilities (₩92.4B).
Debt to Equity History and Analysis
Debt Level: A302440 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A302440's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A302440's debt is well covered by operating cash flow (169%).
Interest Coverage: A302440 earns more interest than it pays, so coverage of interest payments is not a concern.